Ayobami T Akenroye (Ayobami Akenroye)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Venues

Allergy

American journal of respiratory and critical care medicine

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

ERJ open research

This page only lists publications with an associated author ORCID identifier.

Publications

Ratko Djukanović, Paul Brinkman, Johan Kolmert, Cristina Gomez, James Schofield, Joost Brandsma, Andy Shapanis, Paul J S Skipp, Anthony Postle, Craig E Wheelock, Sven-Erik Dahlen, Peter J Sterk, Thomas Brown, David J Jackson, Adel Hasan Mansur, Ian Pavord, Mitesh Patel, Christopher Brightling, Salman Siddiqui, Peter Bradding, Ian Sabroe, Dinesh Saralaya, Livingstone Chishimba, Joanna C Porter, Douglas Robinson, Stephen J Fowler, Peter H Howarth, Louisa Little, Thomas Oliver, Kayleigh Hill, Louise Stanton, Alexander Allen, Deborah Ellis, Gareth Griffiths, Tim Harrison, Ayobami T Akenroye, Jessica Lasky-Su, Liam Heaney, Rekha Chaudhuri, Ramesh Kurukulaaratchy
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic, Omalizumab, in Severe Asthma in Adults: Results of the SoMOSA Study. American journal of respiratory and critical care medicine (2024)
Javier S Cabrera-Perez, Philippe A Eigenmann, Ayobami T Akenroye
Editorial comment on "Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study)". Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 35 (4) (2024)
Ratko Djukanović, Paul Brinkman, Johan Kolmert, Cristina Gomez, James Schofield, Joost Brandsma, Andy Shapanis, Paul J S Skipp, Anthony Postle, Craig E Wheelock, Sven-Erik Dahlen, Peter J Sterk, Thomas Brown, David J Jackson, Adel Hasan Mansur, Ian Pavord, Mitesh Patel, Christopher Brightling, Salman Siddiqui, Peter Bradding, Ian Sabroe, Dinesh Saralaya, Livingstone Chishimba, Joanna C Porter, Douglas Robinson, Stephen J Fowler, Peter H Howarth, Louisa Little, Thomas Oliver, Kayleigh Hill, Louise Stanton, Alexander Allen, Deborah Ellis, Gareth Griffiths, Tim Harrison, Ayobami T Akenroye, Jessica Lasky-Su, Liam Heaney, Rekha Chaudhuri, Ramesh Kurukulaaratchy, null null
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study. American journal of respiratory and critical care medicine 210 (3) (2024)
Ratko Djukanović, Paul Brinkman, Johan Kolmert, Cristina Gomez, James Schofield, Joost Brandsma, Andy Shapanis, Paul J S Skipp, Anthony Postle, Craig E Wheelock, Sven-Erik Dahlén, Peter J Sterk, Thomas Brown, David J Jackson, Adel Hasan Mansur, Ian Pavord, Mitesh Patel, Christopher Brightling, Salman Siddiqui, Peter Bradding, Ian Sabroe, Dinesh Saralaya, Livingstone Chishimba, Joanna C Porter, Douglas Robinson, Stephen J Fowler, Peter H Howarth, Louisa Little, Thomas Oliver, Kayleigh Hill, Louise Stanton, Alexander Allen, Deborah Ellis, Gareth Griffiths, Tim Harrison, Ayobami T Akenroye, Jessica Lasky-Su, Liam Heaney, Rekha Chaudhuri, Ramesh Kurukulaaratchy
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic, Omalizumab, in Severe Asthma in Adults: Results of the SoMOSA Study. American journal of respiratory and critical care medicine (2024)
Tanawin Nopsopon, Yulu Chen, Qingwen Chen, Craig E Wheelock, Scott T Weiss, Michael J McGeachie, Jessica Lasky-Su, Ayobami T Akenroye
Untargeted metabolomic analysis reveals different metabolites associated with response to mepolizumab and omalizumab in asthma. ERJ open research 10 (4) (2024)
Ayobami T Akenroye, Corinne Keet
Emulating Hypothetical Target Trials of the Broad-Spectrum T2 Biologic Dupilumab. Annals of the American Thoracic Society 21 (7) (2024)
Tanawin Nopsopon, Nora A Barrett, Wanda Phipatanakul, Tanya M Laidlaw, Scott T Weiss, Ayobami T Akenroye
Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab. Allergy (2024)
Tanawin Nopsopon, Nora A Barrett, Wanda Phipatanakul, Tanya M Laidlaw, Scott T Weiss, Ayobami T Akenroye
Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab. Allergy 79 (5) (2024)
Lydia Su Yin Wong, Ayobami T Akenroye, Philippe Eigenmann, Elizabeth Huiwen Tham
Editorial comments on "Asthma and rhinitis control in adolescents and young adults: A real-world MASK-air study". Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 35 (5) (2024)
Ratko Djukanović, Paul Brinkman, Johan Kolmert, Cristina Gomez, James Schofield, Joost Brandsma, Andy Shapanis, Paul J S Skipp, Anthony Postle, Craig E Wheelock, Sven-Erik Dahlen, Peter J Sterk, Thomas Brown, David J Jackson, Adel Hasan Mansur, Ian Pavord, Mitesh Patel, Christopher Brightling, Salman Siddiqui, Peter Bradding, Ian Sabroe, Dinesh Saralaya, Livingstone Chishimba, Joanna C Porter, Douglas Robinson, Stephen J Fowler, Peter H Howarth, Louisa Little, Thomas Oliver, Kayleigh Hill, Louise Stanton, Alexander Allen, Deborah Ellis, Gareth Griffiths, Tim Harrison, Ayobami T Akenroye, Jessica Lasky-Su, Liam Heaney, Rekha Chaudhuri, Ramesh Kurukulaaratchy, null null
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study. American journal of respiratory and critical care medicine 210 (3) (2024)
Ayobami T Akenroye, Corinne Keet
Emulating Hypothetical Target Trials of the Broad-Spectrum T2 Biologic Dupilumab. Annals of the American Thoracic Society 21 (7) (2024)
Tanawin Nopsopon, Nora A Barrett, Wanda Phipatanakul, Tanya M Laidlaw, Scott T Weiss, Ayobami T Akenroye
Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab. Allergy 79 (5) (2024)
Tanawin Nopsopon, Yulu Chen, Qingwen Chen, Craig E Wheelock, Scott T Weiss, Michael J McGeachie, Jessica Lasky-Su, Ayobami T Akenroye
Untargeted metabolomic analysis reveals different metabolites associated with response to mepolizumab and omalizumab in asthma. ERJ open research 10 (4) (2024)
Javier S Cabrera-Perez, Philippe A Eigenmann, Ayobami T Akenroye
Editorial comment on "Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study)". Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 35 (4) (2024)
Ratko Djukanović, Paul Brinkman, Johan Kolmert, Cristina Gomez, James Schofield, Joost Brandsma, Andy Shapanis, Paul J S Skipp, Anthony Postle, Craig E Wheelock, Sven-Erik Dahlen, Peter J Sterk, Thomas Brown, David J Jackson, Adel Hasan Mansur, Ian Pavord, Mitesh Patel, Christopher Brightling, Salman Siddiqui, Peter Bradding, Ian Sabroe, Dinesh Saralaya, Livingstone Chishimba, Joanna C Porter, Douglas Robinson, Stephen J Fowler, Peter H Howarth, Louisa Little, Thomas Oliver, Kayleigh Hill, Louise Stanton, Alexander Allen, Deborah Ellis, Gareth Griffiths, Tim Harrison, Ayobami T Akenroye, Jessica Lasky-Su, Liam Heaney, Rekha Chaudhuri, Ramesh Kurukulaaratchy, null null
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study. American journal of respiratory and critical care medicine 210 (3) (2024)
Tanawin Nopsopon, Nora A Barrett, Wanda Phipatanakul, Tanya M Laidlaw, Scott T Weiss, Ayobami T Akenroye
Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab. Allergy 79 (5) (2024)
Tanawin Nopsopon, Yulu Chen, Qingwen Chen, Craig E Wheelock, Scott T Weiss, Michael J McGeachie, Jessica Lasky-Su, Ayobami T Akenroye
Untargeted metabolomic analysis reveals different metabolites associated with response to mepolizumab and omalizumab in asthma. ERJ open research 10 (4) (2024)
Ratko Djukanović, Paul Brinkman, Johan Kolmert, Cristina Gomez, James Schofield, Joost Brandsma, Andy Shapanis, Paul J S Skipp, Anthony Postle, Craig E Wheelock, Sven-Erik Dahlen, Peter J Sterk, Thomas Brown, David J Jackson, Adel Hasan Mansur, Ian Pavord, Mitesh Patel, Christopher Brightling, Salman Siddiqui, Peter Bradding, Ian Sabroe, Dinesh Saralaya, Livingstone Chishimba, Joanna C Porter, Douglas Robinson, Stephen J Fowler, Peter H Howarth, Louisa Little, Thomas Oliver, Kayleigh Hill, Louise Stanton, Alexander Allen, Deborah Ellis, Gareth Griffiths, Tim Harrison, Ayobami T Akenroye, Jessica Lasky-Su, Liam Heaney, Rekha Chaudhuri, Ramesh Kurukulaaratchy, null null
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study. American journal of respiratory and critical care medicine 210 (3) (2024)
Tanawin Nopsopon, Nora A Barrett, Wanda Phipatanakul, Tanya M Laidlaw, Scott T Weiss, Ayobami T Akenroye
Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab. Allergy 79 (5) (2024)
Tanawin Nopsopon, Nora A Barrett, Wanda Phipatanakul, Tanya M Laidlaw, Scott T Weiss, Ayobami T Akenroye
Lung function trajectories in a cohort of patients with moderate-to-severe asthma on mepolizumab, omalizumab, or dupilumab. Allergy 79 (5) (2024)
Ratko Djukanović, Paul Brinkman, Johan Kolmert, Cristina Gomez, James Schofield, Joost Brandsma, Andy Shapanis, Paul J S Skipp, Anthony Postle, Craig E Wheelock, Sven-Erik Dahlen, Peter J Sterk, Thomas Brown, David J Jackson, Adel Hasan Mansur, Ian Pavord, Mitesh Patel, Christopher Brightling, Salman Siddiqui, Peter Bradding, Ian Sabroe, Dinesh Saralaya, Livingstone Chishimba, Joanna C Porter, Douglas Robinson, Stephen J Fowler, Peter H Howarth, Louisa Little, Thomas Oliver, Kayleigh Hill, Louise Stanton, Alexander Allen, Deborah Ellis, Gareth Griffiths, Tim Harrison, Ayobami T Akenroye, Jessica Lasky-Su, Liam Heaney, Rekha Chaudhuri, Ramesh Kurukulaaratchy, null null
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study. American journal of respiratory and critical care medicine 210 (3) (2024)
Ayobami T Akenroye, Omer Kalayci, Philippe A Eigenmann
From preschool wheezing to asthma: Determinants. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 34 (10) (2023)
Philippe A Eigenmann, Ayobami T Akenroye, Marina Atanaskovic-Markovic, Fabio Candotti, Motohiro Ebisawa, Jon Genuneit, Omer Kalayci, Doris Kollmann, Agnes Sze-Yin Leung, Rachel Louise Peters, Carmen Riggioni
Pediatric Allergy and Immunology (PAI) is for polishing with artificial intelligence, but careful use. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 34 (9) (2023)
Ayobami T Akenroye, Wanda Phipatanakul
Editorial comment on "Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in Spain". Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 34 (7) (2023)
Audrey Kamga, Enrica Manca, Davide Paolo Caimmi, Philippe A Eigenmann, Ayobami T Akenroye
Editorial comment on: "Developing a prediction model of children's asthma risk using population-based family history health records". Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 34 (12) (2023)
Ayobami T Akenroye, Guohai Zhou, John W Jackson, Jodi B Segal, G Caleb Alexander, Sonal Singh
Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study. Allergy (2022)
Ayobami T Akenroye, Abayomi Ajala, Elham Azimi-Nekoo, Gabriele S de Vos
Prevalence of anaphylaxis among adults admitted to critical care for severe asthma exacerbation. Emergency medicine journal : EMJ 35 (10) (2018)

Ayobami T Akenroye.css-eqlu8i{font-size:small;padding-left:4px;} (Ayobami Akenroye)

Publication Activity (10 Years)

Top Topics

Top Venues

Ayobami T Akenroye (Ayobami Akenroye)